73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study.
Saved in:
| Title: | 73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study. |
|---|---|
| Authors: | He, A R1 (AUTHOR), Weiss, G J2 (AUTHOR), Falchook, G3 (AUTHOR), Yee, N S4 (AUTHOR), Gil-Martin, M5 (AUTHOR), Shahda, S6 (AUTHOR), Moreno, V7 (AUTHOR), Brana, I8 (AUTHOR), Crittenden, M9 (AUTHOR), Formenti, S10 (AUTHOR), Al-Rajabi, R11 (AUTHOR), Papadopoulos, K P12 (AUTHOR), Pishvaian, M J1 (AUTHOR), Stankevich, E13 (AUTHOR), Feng, M13 (AUTHOR), Li, J14 (AUTHOR), Mathias, M15 (AUTHOR), Kroog, G15 (AUTHOR), Lowy, I15 (AUTHOR), Fury, M G15 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 133734935 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22He%2C+A+R%22">He, A R</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weiss%2C+G+J%22">Weiss, G J</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falchook%2C+G%22">Falchook, G</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yee%2C+N+S%22">Yee, N S</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gil-Martin%2C+M%22">Gil-Martin, M</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shahda%2C+S%22">Shahda, S</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreno%2C+V%22">Moreno, V</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brana%2C+I%22">Brana, I</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crittenden%2C+M%22">Crittenden, M</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Formenti%2C+S%22">Formenti, S</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Rajabi%2C+R%22">Al-Rajabi, R</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Papadopoulos%2C+K+P%22">Papadopoulos, K P</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pishvaian%2C+M+J%22">Pishvaian, M J</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stankevich%2C+E%22">Stankevich, E</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feng%2C+M%22">Feng, M</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+J%22">Li, J</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mathias%2C+M%22">Mathias, M</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kroog%2C+G%22">Kroog, G</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lowy%2C+I%22">Lowy, I</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fury%2C+M+G%22">Fury, M G</searchLink><relatesTo>15</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133734935 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy487.004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: He, A R – PersonEntity: Name: NameFull: Weiss, G J – PersonEntity: Name: NameFull: Falchook, G – PersonEntity: Name: NameFull: Yee, N S – PersonEntity: Name: NameFull: Gil-Martin, M – PersonEntity: Name: NameFull: Shahda, S – PersonEntity: Name: NameFull: Moreno, V – PersonEntity: Name: NameFull: Brana, I – PersonEntity: Name: NameFull: Crittenden, M – PersonEntity: Name: NameFull: Formenti, S – PersonEntity: Name: NameFull: Al-Rajabi, R – PersonEntity: Name: NameFull: Papadopoulos, K P – PersonEntity: Name: NameFull: Pishvaian, M J – PersonEntity: Name: NameFull: Stankevich, E – PersonEntity: Name: NameFull: Feng, M – PersonEntity: Name: NameFull: Li, J – PersonEntity: Name: NameFull: Mathias, M – PersonEntity: Name: NameFull: Kroog, G – PersonEntity: Name: NameFull: Lowy, I – PersonEntity: Name: NameFull: Fury, M G IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 12 Text: 2018 Supplement Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 29 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |